Target intelligence / Profile preview

ABHD17A pseudogene 7 (ABHD17AP7)

Target: ABHD17AP7
Molecular classification: Other (Pseudogene)

Overview

ABHD17A pseudogene 7 (abbreviated as ABHD17AP7) is a processed pseudogene related to the ABHD17A gene in humans. It does not encode a functional protein and is considered a pseudogene, not a protein-coding gene or classic therapeutic target[3][5][7]. Its only documented alias is FAM108A8P[3]. There is no evidence it serves as a drug target, has known biological activities, or is implicated in disease. Pseudogenes can have regulatory roles in some contexts, but there is no published information supporting such a role for ABHD17AP7 specifically.

Other names: FAM108A8P

Beyond the preview

Go deeper on ABHD17A pseudogene 7 (ABHD17AP7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ABHD17A pseudogene 7 (ABHD17AP7).

Explore the full profile